SLC25A28 and glioblastoma: In contrast, the expression of MFRN2 mRNA was downregulated in the GBM samples (Figure 1D,E) and did not correlate with a difference in OS (high median MFRN2 expression: OS = 12.7 months; low median MFRN2 expression: OS = 14.0 months; p = 0.58 by log-rank test) (Figure 1F).